Funding Rounds
Nanoligent

Nanoligent Seed (2022, $1M)

Nanoligent

Research and development of innovative cancer treatments using protein nanoparticles for clinical phases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $1.13M

Raised Date: 2022-01-01

Investors